Quantcast

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013

November 5, 2013

Reportbuyer.com just published a new market research report: Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013

London (PRWEB) November 05, 2013

Summary

GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013" provides data on the Pre-Diabetes/Impaired Glucose Tolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pre-Diabetes/Impaired Glucose Tolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner

-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

-Obtain discontinued trial listing for trials across the globe

-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Introduction 8

Pre-Diabetes/Impaired Glucose Tolerance 8

Report Guidance 8

Clinical Trials by Region 9

Clinical Trials by Country 10

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by BRIC Nations 17

Clinical Trials by G7 Nations 18

Clinical Trials in G7 Nations by Trial Status 19

Clinical Trials by E7 Nations 20

Clinical Trials in E7 Nations by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Unaccomplished Trials of Pre-Diabetes/Impaired Glucose Tolerance 25

Subjects Recruited Over a Period of Time 29

Prominent Sponsors 30

Top Companies Participating in Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials 32

Prominent Drug Comparison 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

Novartis AG 35

Clinical Trial Overview of Novartis AG 35

Genfit SA 36

Clinical Trial Overview of Genfit SA 36

Sanofi 37

Clinical Trial Overview of Sanofi 37

Novo Nordisk A/S 38

Clinical Trial Overview of Novo Nordisk A/S 38

Merck & Co., Inc. 39

Clinical Trial Overview of Merck & Co., Inc. 39

Generex Biotechnology Corporation 40

Clinical Trial Overview of Generex Biotechnology Corporation 40

Limerick BioPharma, Inc. 41

Clinical Trial Overview of Limerick BioPharma, Inc. 41

NuMe Health LLC 42

Clinical Trial Overview of NuMe Health LLC 42

KineMed, Inc. 43

Clinical Trial Overview of KineMed, Inc. 43

Arete Therapeutics Inc. 44

Clinical Trial Overview of Arete Therapeutics Inc. 44

New Chapter, Inc. 45

Clinical Trial Overview of New Chapter, Inc. 45

Cadila Pharmaceuticals Ltd. 46

Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 46

Resverlogix Corp. 47

Clinical Trial Overview of Resverlogix Corp. 47

Bayer AG 48

Clinical Trial Overview of Bayer AG 48

UnitedHealth Group Incorporated 49

Clinical Trial Overview of UnitedHealth Group Incorporated 49

Marico Limited 50

Clinical Trial Overview of Marico Limited 50

Forest Laboratories, Inc. 51

Clinical Trial Overview of Forest Laboratories, Inc. 51

Takeda Pharmaceutical Company Limited 52

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 52

Bioneer Corporation 53

Clinical Trial Overview of Bioneer Corporation 53

Daiichi Sankyo Company, Limited 54

Clinical Trial Overview of Daiichi Sankyo Company, Limited 54

Clinical Trial Overview of Top Institutes / Government 55

The National Institute of Diabetes and Digestive and Kidney Diseases 55

Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 55

U.S. Department of Veterans Affairs 56

Clinical Trial Overview of U.S. Department of Veterans Affairs 56

Yale University 57

Clinical Trial Overview of Yale University 57

University of Toronto 58

Clinical Trial Overview of University of Toronto 58

University of Eastern Finland 59

Clinical Trial Overview of University of Eastern Finland 59

Maastricht University Medical Center 60

Clinical Trial Overview of Maastricht University Medical Center 60

University of Leipzig 61

Clinical Trial Overview of University of Leipzig 61

National Taiwan University Hospital 62

Clinical Trial Overview of National Taiwan University Hospital 62

Eunice Kennedy Shriver National Institute of Child Health and Human Development 63

Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 63

Pennington Biomedical Research Foundation 64

Clinical Trial Overview of Pennington Biomedical Research Foundation 64

Mayo Clinic 65

Clinical Trial Overview of Mayo Clinic 65

University of Minnesota 66

Clinical Trial Overview of University of Minnesota 66

Duke University 67

Clinical Trial Overview of Duke University 67

Stanford University 68

Clinical Trial Overview of Stanford University 68

Beth Israel Deaconess Medical Center 69

Clinical Trial Overview of Beth Israel Deaconess Medical Center 69

Chinese University of Hong Kong 70

Clinical Trial Overview of Chinese University of Hong Kong 70

Emory University 71

Clinical Trial Overview of Emory University 71

Karolinska Institutet 72

Clinical Trial Overview of Karolinska Institutet 72

Mount Sinai School of Medicine 73

Clinical Trial Overview of Mount Sinai School of Medicine 73

The University of Chicago 74

Clinical Trial Overview of The University of Chicago 74

Five Key Clinical Profiles 75

Appendix 104

Abbreviations 104

Definitions 104

Research Methodology 105

Secondary Research 105

About GlobalData 106

Contact Us 106

Disclaimer 106

Source 107

List of Tables

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, North America, Top Countries, 2013* 14

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, BRIC Countries, 2013* 17

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, G7 Countries, 2013* 18

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, E7 Countries, 2013* 20

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Suspended Clinical Trials, 2013* 25

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 26

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 35

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2013* 36

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 37

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2013* 38

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 39

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Generex Biotechnology Corporation, 2013* 40

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Limerick BioPharma, Inc., 2013* 41

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by NuMe Health LLC, 2013* 42

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by KineMed, Inc., 2013* 43

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Arete Therapeutics Inc., 2013* 44

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by New Chapter, Inc., 2013* 45

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2013* 46

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Resverlogix Corp., 2013* 47

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 48

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by UnitedHealth Group Incorporated, 2013* 49

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Marico Limited, 2013* 50

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 51

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2013* 52

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioneer Corporation, 2013* 53

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 54

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2013* 55

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 56

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2013* 57

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2013* 58

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Eastern Finland, 2013* 59

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2013* 60

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2013* 61

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 62

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2013* 63

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Pennington Biomedical Research Foundation, 2013* 64

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 65

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2013* 66

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 67

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013* 68

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2013* 69

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2013* 70

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 71

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2013* 72

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2013* 73

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 74

List of Figures

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, G7 Countries (%), 2013* 18

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, E7 Countries (%), 2013* 20

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34

GlobalData Methodology 105

Read the full report:

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/pre_diabetes_impaired_glucose_tolerance_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/11/prweb11303486.htm


Source: prweb



comments powered by Disqus